SpikImm
PrivateLast Round
Grant
Dec 7, 2022
Total Funding Raised
$15.8M
Company Overview
SpikImm operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Grant round in December 2022.
SpikImm is a biotechnology company that develops monoclonal antibodies for the treatment and prevention of viral infections, initially focusing on COVID-19.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpikImm Comparables
Compare SpikImm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Invivyd | 82% | |
| RQ Biotechnology Limited | 82% | |
| Ipsen | 81% |
For institutional investors. Book with your work email.
SpikImm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 7, 2022 | ||||
| Seed | May 6, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SpikImm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Truffle Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2021
Seed round led by Truffle Capital.
For institutional investors. Book with your work email.
SpikImm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SpikImm's valuation, stock price, and market status.
Is SpikImm a public or private company?
SpikImm is a private company.
What is the current stock price of SpikImm?
SpikImm is a private company with no public stock price. Caplight tracks SpikImm's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is SpikImm worth (valuation)?
Valuation information for SpikImm is not publicly available.
Can I buy SpikImm stock?
SpikImm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SpikImm's last funding round?
SpikImm's most recent funding round was Grant on December 7, 2022.
Who are the main investors in SpikImm?
Key investors in SpikImm include Truffle Capital.
Will SpikImm IPO soon?
No public IPO plans have been announced for SpikImm.
How can I track SpikImm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SpikImm's secondary market activity and sign up for updates.